Apple Hit With $634 Million Verdict in Apple Watch Blood Oxygen Patent Lawsuit
A U.S. federal jury has ruled that Apple owes medical technology company Masimo $634 million for patent infringement related to the blood oxygen-sensing technology in the Apple Watch, reports Reuters. Apple will appeal the verdict.
"We are pleased by this outcome, and appreciate the time and attention given to our case by the court and the jury," said Masimo in a press release." This is a significant win in our ongoing efforts to protect our innovations and intellectual property, which is crucial to our ability to develop technology that benefits patients. We remain committed to defending our IP rights moving forward."
"Over the past six years (Masimo has) sued Apple in multiple courts and asserted over 25 patents, the majority of which have been found to be invalid," an Apple spokesperson told Reuters. "The single patent in this case expired in 2022, and is specific to historic patient monitoring technology from decades ago."
The patent dispute led to a ban on U.S. sales of Apple Watch with the blood oxygen feature in December 2023. Apple was able to temporarily continue selling the Apple Watch models while an interim stay was in place during an appeal, but the ban was reinstated as of January 18, 2024, and Apple addressed the issue by immediately launching sales of models with the feature disabled in software.
Apple Watch models in the U.S. remained unable to support blood oxygen monitoring for over a year and a half before Apple introduced a workaround in August 2025 with blood oxygen data being processed and displayed on a paired iPhone rather than on the Apple Watch itself, a change that satisfied U.S. Customs regulators that had been charged with enforcing the original ban.
Apple's workaround did not sit well with Masimo, which filed another lawsuit in an attempt to overturn the U.S. Customs decision and once again prevent Apple from selling Apple Watch models with the blood oxygen feature in the U.S., but there has yet to be a ruling in that lawsuit.
Popular Stories
Last year, Apple launched CarPlay Ultra, the long-awaited next-generation version of its CarPlay software system for vehicles. Nearly nine months later, CarPlay Ultra is still limited to Aston Martin's latest luxury vehicles, but that should change fairly soon.
In May 2025, Apple said many other vehicle brands planned to offer CarPlay Ultra, including Hyundai, Kia, and Genesis.
In his Powe...
The calendar has turned to February, and a new report indicates that Apple's next product launch is "imminent," in the form of new MacBook Pro models.
"All signs point to an imminent launch of next-generation MacBook Pros that retain the current form factor but deliver faster chips," Bloomberg's Mark Gurman said on Sunday. "I'm told the new models — code-named J714 and J716 — are slated...
Apple is planning to launch new MacBook Pro models with M5 Pro and M5 Max chips alongside macOS 26.3, according to Bloomberg's Mark Gurman.
"Apple's faster MacBook Pros are planned for the macOS 26.3 release cycle," wrote Gurman, in his Power On newsletter today.
"I'm told the new models — code-named J714 and J716 — are slated for the macOS 26.3 software cycle, which runs from...
We are still waiting for the iOS 26.3 Release Candidate to come out, so the first iOS 26.4 beta is likely still at least a week or two away. Following beta testing, iOS 26.4 will likely be released to the general public in March or April.
Below, we have recapped known or rumored iOS 26.3 and iOS 26.4 features so far.
iOS 26.3
iPhone to Android Transfer Tool
iOS 26.3 makes it easier...
Apple recently updated its online store with a new ordering process for Macs, including the MacBook Air, MacBook Pro, iMac, Mac mini, Mac Studio, and Mac Pro.
There used to be a handful of standard configurations available for each Mac, but now you must configure a Mac entirely from scratch on a feature-by-feature basis. In other words, ordering a new Mac now works much like ordering an...
